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Abstract
Background: There is some initial evidence that an enhanced physical activity level can improve fquality of life,
and possibly survival among patients with lung cancer. The primary aim of this project was to evaluate the impact
of physical activity on the quality and quantity of life of lung cancer survivors.
Methods: Between January 1, 1997, and December 31, 2009, a total of 1466 lung cancer survivors completed a
questionnaire with patient-reported outcomes for quality of life (QOL), demographics, disease and clinical
characteristics, and a measure of physical activity (Baecke Questionnaire). Chi-square tests compared lung cancer
survivors who reported being physically active versus not on a variety of the other covariates. Kaplan-Meier
estimates and Cox models evaluated the prognostic importance of physical activity level on Overall Survival (OS).
Results: Roughly half of the lung cancer survivors had advanced stage disease at the time of survey. Treatment
prevalence rates were 61, 54, and 33 % for surgery, chemotherapy and radiotherapy, respectively. The majority
(77 %) of survivors reported themselves as physically active. Physically active survivors reported greater activity
across all individual Baecke items. Lung cancer survivor-reported QOL indicated the benefits of physical activity in
all domains. Survivors receiving chemotherapy or radiation at the time of questionnaire completion were less likely
to be physically active (74 and 73 % respectively). In contrast, 84 % of surgical patients were physically active.
Disease recurrence rates were the same for physically active and inactive patients (81 % vs 82 %, p = 0.62). Physically
active patients survived an average of 4 more years than those who were not physically active (8.4 years versus
4.4 years respectively, log rank p < 0.0001).
Conclusions: Being physically active was related to profound advantages in QOL and survival in a large sample of
lung cancer survivors.
Background
There is some initial evidence that an enhanced physical
activity level can improve feelings of well-being, quality
of life, and possibly survival among patients with lung
cancer [1]. In general the impact of exercise behaviors
following a cancer diagnoses has been most extensively
investigated for patients with breast and gastrointestinal
malignancies [2, 3]. However, accruing evidence suggests
that exercise behaviors may be an important and action-
able determinant of lung cancer outcomes. The potential
for a novel, non-toxic therapy warrants attention, since
lung cancer, the most common cause of cancer death, has
a tendency for late-stage diagnosis and, despite novel drug
therapies, rapid, morbid, and inexorable progression [4].
To date a range of both cross-sectional and longitu-
dinal studies have examined associations between aer-
obic fitness and important outcomes at seminal points
along the lung cancer trajectory. With few exceptions,
investigators have characterized aerobic fitness at a sin-
gle time point using maximal oxidative capacity (V02max)
or 6 min walk distance (6MWD). Cross sectional investi-
gations have shown that aerobic fitness is associated
with post-operative symptom burden and quality of life
among patients with operable lung cancer [5, 6].
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Longitudinal investigations have demonstrated that aer-
obic fitness predicts peri-operative complication rates
for lung cancer surgeries, [7–9] as well as overall sur-
vival for both operable [1] and inoperable [10] lung can-
cer. Encouragingly, pilot studies have found exercise-
based pulmonary rehabilitation programs, both pre- and
post-operative, to be well tolerated and to enhance aer-
obic fitness [9, 11–13]. Even patients with late stage lung
cancer derive benefit from exercise training as manifest
in improved a functional capacity and a reduced symp-
tom burden [14–16].
Despite mounting evidence attesting the benefits of
enhanced physical activity among lung cancer survivors,
the longitudinal impact of shifting activity levels follow-
ing a lung cancer diagnosis has yet to be examined using
repeated measures. Our group previously reported that
endorsement of regular physical activity among 272
long-term lung cancer survivors was associated with
higher scores in overall QOL and all QOL sub-domains,
as well as a reduced symptom burden [26]. The primary
aim of this project was to prospectively examine the rela-
tionship of physical activity level with quality of life and
overall survival across multiple time points in a larger co-
hort of 1466 long-term lung cancer survivors. Secondary
aims included examining the influence of treatment and
demographic variables on these relationships and describ-
ing differences between survivors who did and did not
characterize themselves as being physically active.
Methods
The Mayo Clinic Epidemiology and Genetics of Lung
Cancer Research Program has enrolled and prospect-
ively followed patients either diagnosed with and/or
treated for lung cancer at Mayo Clinic, Rochester,
Minnesota since its inception in 1997. Between
January 1, 1997, and December 31, 2009, over 10,000
patients have been enrolled. Procedures for identifying
and following lung cancer patients enrolled in this
program have been previously described [17]. Patient
follow-up was accomplished by mailed questionnaire
beginning at six months after diagnosis and annually
thereafter.
Quality of life was assessed at all follow-up time points
by means of one item from the Lung Cancer Symptom
Scale (LCSS) [18, 19]. The overall QOL item served as
the primary endpoint in the current study. In the pri-
mary analysis overall QOL is considered as a continuous
variable, taking integer values from 0 to 100. Previously,
The North Central Cancer treatment Group (NCCTG)
Lung Cancer Committee compared alternative QOL as-
sessments (the European Organization for the Research
and Treatment of Cancer Quality of Life Questionnaire
and Lung Cancer Module(EORTC-QLQ-LC13), the
Functional Assessment of Cancer Therapy - Lung
(FACT-L), and the Lung Cancer Symptom Scale(LCSS))
using a series of phase II clinical trials (NCCTG trials
95-20-53, 95-24-52, 96-24-51, 98-24-52). Ultimately it
was found that the LCSS performed as well as the
other two assessments and used fewer items to obtain
the same information [20]. A pooled analysis of lung
cancer studies indicated that the single-item QOL as-
sessments developed within the NCCTG were more
sensitive to change than longer, multi-item assess-
ments [21]. This study also demonstrated that the
relationship between QOL assessments and toxicity
was modest at best and that clinically meaningful
changes in QOL preceded adverse events captured by
the Common Toxicity Criteria(CTC) by two to three
months.
These single-item assessments have become the most-
used assessment in all NCI-sponsored cancer control
studies [22] and have been validated extensively against
more involved assessment processes [23, 24]. Normative
data have been obtained from various clinical popula-
tions enrolled in NCCTG clinical trials and from healthy
participants attending an NCCTG annual meeting. In
assessing overall QOL on a 0–100 point scale, healthy
volunteers will average about 82, hospice patients will
average 78, advanced cancer patients will average some-
where between 60 and 75, newly diagnosed patients will
average between 50 and 60. A score of 50 or below is in-
dicative of a need for immediate exploration and inter-
vention for the QOL deficit [25]. This cutoff has been
validated both by our research team [21, 26] and in-
dependently by others [27–29]. We recently published
data indicating that these measures held prognostic
power specifically among lung cancer patients [30]. The
NCCTG has included Linear Analog Scale Assessmen-
t(LASA) measures for overall QOL and fatigue in all
phase II and phase III clinical trials since 2009 as an inde-
pendent prognostic factor independent of performance
status.
Self-reported physical activity and health promotion
behaviors were provided by the lung cancer survivors
using the modified Baecke questionnaire for physical
activity [31]. First developed for epidemiological stud-
ies of physical activity in a Dutch population [32], the
16-item questionnaire consists of three subscales: 1)
physical activity at work; 2) sport during leisure time;
and 3) physical activity during leisure time excluding
sport [33]. It has been used in healthy, elderly, and
chronic fatigue populations successfully [34–36]. Re-
cent studies have idenitifed issues with its validity and
reliability, but it remains the most often-used ques-
tionnaire for assessing physical activity in epidemio-
logical studies [37]. Specifically, it has been suggested
that the Baecke questionnaire is best used to differen-
tiate between active and inactive individuals rather
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Table 1 Participant characteristics for 1466 lung cancer survivors by Baecke physical activity data
Participant characteristic Non-physically active (N = 331) Physically active (N = 1135) Total (N = 1466)
Age at diagnosis
N 331 1135 1466
Mean (SD) 68.7 (9.73) 64.9 (10.82) 65.7 (10.7)
Range (35.0–91.0) (18.0–93.0) (18–93)
Gender
Female 158 (47.7 %) 568 (50 %) 726 (49.5 %)
Male 173 (52.3 %) 567 (50 %) 740 (50.5 %)
Race
Caucasian 311 (94 %) 1059 (93.3 %) 1370 (93.5 %)
Hispanic 4 (1.2 %) 8 (0.7 %) 12 (0.8 %)
Alaskan/Indian 15 (4.5 %) 54 (4.8 %) 69 (4.7 %)
Black 1 (0.3 %) 3 (0.3 %) 4 (0.3 %)
Asian/Pacific Islander 0 (0.0 %) 6 (0.5 %) 6 (0.4 %)
Unknown 0 (0.0 %) 5 (0.4 %) 5 (0.3 %)
Years of schooling completed
N 67 307 374
Mean (SD) 13.0 (2.35) 13.6 (2.41) 13.5 (2.4)
Range (6.0–17.0) (5.0–18.0) (5.0–18.0)
Marital status
Missing 62 185 247
Single 9 (3.3 %) 47 (4.9 %) 56 (4.6 %)
Married 194 (72.1 %) 751 (79.1 %) 945 (77.5 %)
Divorced 27 (10 %) 75 (7.9 %) 102 (8.4 %)
Widowed 39 (14.5 %) 75 (7.9 %) 114 (9.4 %)
Life partner 0 (0.0 %) 2 (0.2 %) 2 (0.2 %)
Vital status (as of 2/2010)
Alive 167 (50.5 %) 787 (69.3 %) 954 (65.1 %)
Dead 164 (49.5 %) 348 (30.7 %) 512 (34.9 %)
Time to last FU (as of 2/2010) in years
N 331 1135 1466
Mean (SD) 2.7 (2.15) 3.3 (2.43) 3.1 (2.38)
Range (0.1–8.6) (0.0–9.0) 2.2
Cigarette smoking status
Never 36 (10.9 %) 218 (19.2 %) 254 (17.3 %)
Former smoker 165 (49.8 %) 615 (54.2 %) 780 (53.2 %)
Current smoker 129 (39 %) 294 (25.9 %) 423 (28.9 %)
Some smoking history 1 (0.3 %) 8 (0.7 %) 9 (0.6 %)
Pack-Years
N 292 910 1202
Mean (SD) 53.2 (34.44) 45.4 (28.29) 47.3 (30.07)
Range (0.5–208.0) (0.0–180.0) (0.0–208.0)
Condensed grade
Missing 1 6 7
1 =Well differentiated 58 (17.6 %) 328 (29.1 %) 386 (26.5 %)
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Table 1 Participant characteristics for 1466 lung cancer survivors by Baecke physical activity data (Continued)
2 =Moderately differentiated 104 (31.5 %) 414 (36.7 %) 518 (35.5 %)
3 = Poorly differentiated 142 (43 %) 321 (28.4 %) 463 (31.7 %)
4 = Non-gradeable 26 (7.9 %) 66 (5.8 %) 92 (6.3 %)
Stage
Missing 6 5 11
Limited 27 (8.3 %) 36 (3.2 %) 63 (4.3 %)
Extensive 22 (6.8 %) 30 (2.7 %) 52 (3.6 %)
Stage IA 49 (15.1 %) 320 (28.3 %) 369 (25.4 %)
Stage IB 48 (14.8 %) 186 (16.5 %) 234 (16.1 %)
Stage IIA 6 (1.8 %) 24 (2.1 %) 30 (2.1 %)
Stage IIB 17 (5.2 %) 68 (6 %) 85 (5.8 %)
Stage IIIA 42 (12.9 %) 124 (11 %) 166 (11.4 %)
Stage IIIB 45 (13.8 %) 116 (10.3 %) 161 (11.1 %)
Stage IV 69 (21.2 %) 226 (20 %) 295 (20.3 %)
T (tumor) of TNM staging
Missing 69 176 245
No primary tumor 6(2.3 %) 10(1.0 %) 16(1.3 %)
Tumor < = 3 cm 83 (31.7 %) 420 (43.8 %) 503 (41.2 %)
Tumor > 3 cm 92 (35.1 %) 309 (32.2 %) 401 (32.8 %)
Invades chest wall 14 (5.3 %) 54 (5.6 %) 68 (5.6 %)
Invades mediastinum 56 (21.4 %) 137 (14.3 %) 193 (15.8 %)
Cannot be assessed 11 (4.2 %) 29 (3 %) 40 (3.3 %)
N (nodes) of TNM staging
Missing 51 123 174
No nodal mets 122 (43.6 %) 611 (60.4 %) 733 (56.7 %)
In Peribr/Hilar 30 (10.7 %) 98 (9.7 %) 128 (9.9 %)
In Medias/Subcarinal 97 (34.6 %) 210 (20.8 %) 307 (23.8 %)
Mets in contralaterl 22 (7.9 %) 76 (7.5 %) 98 (7.6 %)
Nodes Unassessable 9 (3.2 %) 17 (1.7 %) 26 (2 %)
Surgery
Missing 12 27 39
No 179 (56.1 %) 381 (34.4 %) 560 (39.2 %)
Yes 140 (43.9 %) 727 (65.6 %) 867 (60.8 %)
Surgery within 6 months
Missing 12 27 39
No 189 (59.2 %) 435 (39.3 %) 624 (43.7 %)
Yes 130 (40.8 %) 673 (60.7 %) 803 (56.3 %)
Chemotherapy
Missing 12 27 39
No 120 (37.6 %) 542 (48.9 %) 662 (46.4 %)
Yes 199 (62.4 %) 566 (51.1 %) 765 (53.6 %)
Chemotherapy within 6 months
Missing 12 27 39
No 166 (52 %) 686 (61.9 %) 852 (59.7 %)
Yes 153 (48 %) 422 (38.1 %) 575 (40.3 %)
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than to differentiate active people into low and high
activity level categories [38].
The study sample included 1466 lung cancer survi-
vors who completed the Baecke questionnaire at least
once. The study sample used the first Baecke data re-
corded by each survivor to define the participant’s
physical activity level. We found little change over
time in the Baecke scores (data not shown). By using
the first observed Baecke scores, we acknowledge that
the time since diagnosis and years studied will be
variable. The scoring algorithm for the Baecke ques-
tionnaire was untenable because of a large amount of
non-interpretable data. Our study team went through
an extensive data cleaning operation wherein we
made operational definitions and decisions as to how
to record various eccentricities in the data. For ex-
ample, patients provided multiple sports when asked
for their primary sport activity, reported gambling as
a sport, or provided Illogical combinations such as
indicating they engaged in physical exercise during
leisure time regularly for a total of zero minutes per
day. As a result it became clear that we would only
be able to present some subscale data and in reality
could only analyze individual questions with confi-
dence. The study protocol was reviewed and approved
by the Mayo Clinic Institutional Review Board. Ethics
approval of this study was granted by Mayo Clinic
Institutional Review Board. Written informed consent
was obtained from all participants.
Power considerations with 1466 lung cancer survi-
vors, any percentage reported on the entire sample is
accurate to within 2.6 with 95 % confidence. Any
mean reported on such a sample is accurate to within
5 % times the standard deviation(SD) of the continu-
ous variable’s distribution, which is classified as a
small effect size [39]. For example, it is known that
our overall QOL scores that range from 0–100 have a
standard deviation of roughly 16.7 points. This would
mean that the mean QOL reported for this sample
will be accurate to within 1 point on the 0–100 point
scale.
Covariates considered in this study can be broadly
grouped into demographic (age, gender, race, comorbidi-
ties), social (employment status, marital status, years of
education), smoking history (pack years, never, former,
recent quitter, still smoking) disease-related (histology,
stage, grade), and treatment-related (chemotherapy,
radiation, surgery) characteristics. Smoking classifica-
tion was assessed in several ways. First was pack
years, defined as the number of packs of cigarettes
smoked over time. For example, a participant who
smoked one pack of cigarettes per day for 20 years,
would have a 20 year pack history. Participants were
also classified according to smoking status at the time
they completed the survey packet: never smoker (less
than 100 life time cigarettes), former smoker (quit
more than 12 months), recent quitter (quit more than
30 days but less than 12 months), or current smoker
(any tobacco usage in the past 30 days).
Model Building included Cox proportional hazards
models (forward and backward stepping, saturated, and
stepwise approaches) for relating exercise to survival
while controlling for the covariates listed above. Cluster
analysis was employed to identify correlated symptoms
and treatment/disease status, thus reduce dimensionality
of the numerous covariate influences that arose from the
survival models.
Results
Demographics and clinical data are summarized in
Table 1 for the 1466 lung cancer survivors comprising
our sample. Survivors ranged in age from 18 to 93 years
of age with an average age of 66 years (SD = 11 years).
The sample was equally divided between the genders
and 93 % of the sample was Caucasian. Over 90 % grad-
uated high school and the majority was married (78 %).
Follow-up ranged as long as 9 years but averaged
3 years, and 35 % of the possible study participants
were dead at the time of study follow-up. Smoking
behavior past or present was prevalent (83 %) al-
though 17 % of the lung cancer survivors reported
Table 1 Participant characteristics for 1466 lung cancer survivors by Baecke physical activity data (Continued)
Radiation
Missing 12 27 39
No 193 (60.5 %) 769 (69.4 %) 962 (67.4 %)
Yes 126 (39.5 %) 339 (30.6 %) 465 (32.6 %)
Radiation within 6 months
Missing 12 27 39
No 230 (72.1 %) 875 (79 %) 1105 (77.4 %)
Yes 89 (27.9 %) 233 (21 %) 322 (22.6 %)
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Table 2 Individual Baecke item overall distributions by physical activity level
Non-physically active (N = 331) Physically active (N = 1135) Total (N = 1466) p value
Retired <0.0001*
Missing 68 153 221
No 56 (21.3 %) 421 (42.9 %) 477 (38.3 %)
Yes 207 (78.7 %) 561 (57.1 %) 768 (61.7 %)
Employed <0.0001*
Missing 4 6 10
No 285 (87.2 %) 757 (67.1 %) 1042 (71.6 %)
Yes 42 (12.8 %) 372 (32.9 %) 414 (28.4 %)
At work - sit 0.0003*
Missing 283 742 1025
Never 1 (2.1 %) 24 (6.1 %) 25 (5.7 %)
Seldom 0 (0 %) 57 (14.5 %) 57 (12.9 %)
Sometimes 7 (14.6 %) 105 (26.7 %) 112 (25.4 %)
Often 27 (56.3 %) 129 (32.8 %) 156 (35.4 %)
Always/Very Often 13 (27.1 %) 78 (19.8 %) 91 (20.6 %)
At work - stand
Missing 289 745 1034
Never 14 (33.3 %) 39 (10.0 %) 53 (12.3 %)
Seldom 28 (66.7 %) 126 (32.3 %) 154 (35.6 %)
Sometimes 0 (0 %) 140 (35.9 %) 140 (32.4 %)
Often 0 (0 %) 85 (21.8 %) 85 (19.7 %)
At work - walk <0.0001*
Missing 286 745 1031
Never 15 (33.3 %) 35 (9.0 %) 50 (11.5 %)
Seldom 30 (66.7 %) 117 (30.0 %) 147 (33.8 %)
Sometimes 0 (0 %) 166 (42.6 %) 166 (38.2 %)
Often 0 (0 %) 72 (18.5 %) 72 (16.6 %)
At work - lift 0.2175*
Missing 314 860 1174
Never 12 (66.7 %) 138 (50.2 %) 150 (51.4 %)
Seldom 5 (33.3 %) 81 (29.5 %) 86 (29.5 %)
Sometimes 0 (0 %) 42 (15.3 %) 42 (14.4 %)
Often 0 (0 %) 14 (5.1 %) 14 (4.8 %)
At work - sweat 0.0160*
Missing 307 851 1158
Never 14 (58.3 %) 113 (39.8 %) 127 (41.2 %)
Seldom 10 (41.7 %) 95 (33.5 %) 105 (34.1 %)
Sometimes 0 (0 %) 60 (21.1 %) 60 (19.5 %)
Often 0 (0 %) 16 (5.6 %) 16 (5.2 %)
After work - tired 0.0694*
Missing 284 742 1026
Never 3 (6.4 %) 37 (9.4 %) 40 (9.1 %)
Seldom 12 (25.5 %) 155 (39.4 %) 167 (38.0 %)
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Table 2 Individual Baecke item overall distributions by physical activity level (Continued)
Sometimes 15 (31.9 %) 122 (31.0 %) 137 (31.1 %)
Often 17 (36.2 %) 79 (20.1 %) 96 (21.8 %)
Work compared to others 0.0009*
Missing 285 734 1019
Much heavier 1 (2.2 %) 26 (6.5 %) 27 (6.0 %)
Heavier 3 (6.5 %) 50 (12.5 %) 53 (11.9 %)
As heavy 12 (26.1 %) 155 (38.7 %) 167 (37.4 %)
Lighter 19 (41.3 %) 131 (32.7 %) 150 (33.6 %)
Much lighter 11 (23.9 %) 39 (9.7 %) 50 (11.2 %)
Sports or exercise <0.0001*
Missing 15 20 35
No 316 (100 %) 459 (41.2 %) 775 (54.2 %)
Yes 0 (0 %) 656 (58.8 %) 656 (45.8 %)
Second sport or exercise <0.0001*
Missing 275 479 754
No 56 (100 %) 436 (66.5 %) 492 (69.1 %)
Yes 0 (0 %) 220 (33.5 %) 220 (30.9 %)
Sport activity compared to others <0.0001*
Missing 63 84 147
Much more 0 (0 %) 72 (6.9 %) 72 (5.5 %)
More 0 (0 %) 221 (21.0 %) 221 (16.8 %)
The Same 36 (13.4 %) 345 (32.8 %) 381 (28.9 %)
Less 97 (36.2 %) 272 (25.9 %) 369 (28.0 %)
Much Less 135 (50.4 %) 141 (13.4 %) 276 (20.9 %)
Comparison based on frequency 0.0057*
Missing 202 511 713
No 8 (6.2 %) 10 (1.6 %) 18 (2.4 %)
Yes 121 (93.8 %) 614 (98.4 %) 735 (97.6 %)
Comparison based on intensity 0.2262*
Missing 242 740 982
No 11 (12.4 %) 33 (8.4 %) 44 (9.1 %)
Yes 78 (87.6 %) 362 (91.6 %) 440 (90.9 %)
Comparison based on duration 0.5282*
Missing 231 746 977
No 9 (9.0 %) 28 (7.2 %) 37 (7.6 %)
Yes 91 (91.0 %) 361 (92.8 %) 452 (92.4 %)
Leisure - sweat <0.0001*
Missing 20 55 75
Very often 0 (0 %) 55 (5.1 %) 55 (4.0 %)
Often 0 (0 %) 133 (12.3 %) 133 (9.6 %)
Sometimes 94 (30.2 %) 345 (31.9 %) 439 (31.6 %)
Seldom 119 (38.3 %) 364 (33.7 %) 483 (34.7 %)
Never 98 (31.5 %) 183 (16.9 %) 281 (20.2 %)
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that they had never smoked. For those that smoked
the average pack years was 47 years. Roughly half of
the survivors had advanced stage disease at the time
of observation. Treatment prevalence rates were 61,
54, and 33 % for surgery, chemotherapy and radio-
therapy respectively.
Physical activity level of survivors was dichotomized
as physically active or not physically active by the
readiness to change scale as described above. The ma-
jority (77 %) of the 1466 patients who provided a
physical activity classification (6 out of the original
1472 patients did not) reported themselves as being
in the action stage for physical activity based on this
classification. The individual item results for the
Baecke activity questionnaire are given in Table 2.
Survivors who were physically active reported signifi-
cantly different results for almost all of the individual
Baecke items. Almost 62 % of the patients were
retired, while 28 % identified themselves as being
employed. Roughly 45 % of patients reported they
Table 2 Individual Baecke item overall distributions by physical activity level (Continued)
Leisure - Yard or housework <0.0001*
Missing 17 17 34
Very often 0 (0 %) 355 (31.8 %) 355 (24.8 %)
Often 0 (0 %) 433 (38.7 %) 433 (30.2 %)
Sometimes 176 (56.1 %) 211 (18.9 %) 387 (27.0 %)
Seldom 60 (19.1 %) 77 (6.9 %) 137 (9.6 %)
Never 78 (24.8 %) 42 (3.8 %) 120 (8.4 %)
Leisure - watch TV <0.0001*
Missing 9 23 32
Very often 118 (36.6 %) 206 (18.5 %) 324 (22.6 %)
Often 96 (29.8 %) 415 (37.3 %) 511 (35.6 %)
Sometimes 82 (25.5 %) 381 (34.3 %) 463 (32.3 %)
Seldom 13 (4.0 %) 97 (8.7 %) 110 (7.7 %)
Never 13 (4.0 %) 13 (1.2 %) 26 (1.8 %)
Leisure - walk <0.0001*
Missing 17 22 39
Very often 9 (2.9 %) 166 (14.9 %) 175 (12.3 %)
Often 28 (8.9 %) 355 (31.9 %) 383 (26.8 %)
Sometimes 122 (38.9 %) 390 (35.0 %) 512 (35.9 %)
Seldom 106 (33.8 %) 166 (14.9 %) 272 (19.1 %)
Never 49 (15.6 %) 36 (3.2 %) 85 (6.0 %)
Leisure - bicycle <0.0001*
Missing 27 66 93
Very often 1 (0.3 %) 24 (2.2 %) 25 (1.8 %)
Often 4 (1.3 %) 55 (5.1 %) 59 (4.3 %)
Sometimes 14 (4.6 %) 148 (13.8 %) 162 (11.8 %)
Seldom 37 (12.2 %) 186 (17.4 %) 223 (16.2 %)
Never 248 (81.6 %) 656 (61.4 %) 904 (65.8 %)
Leisure - Walk/bike minutes per day <0.0001**
N 171 695 866
Mean (SD) 6.9 (15.1) 18.7 (32.7) 16.3 (30.4)
Median 0.0 10.0 5.0
Q1, Q3 0.0, 10.0 0.0, 30.0 0.0, 30.0
Range (0–120) (0–600) (0–600)
*Chi-square test, **Wilcoxon
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participated regularly in sports or exercise an average
of 6 h per week. Roughly half of the survivors indi-
cated that they thought they participated in sport
activity less than others. Over three quarters of the
survivors reported that they engaged in cycling on at
least a semi-regular basis. Roughly 15 % (208 out
1427) of patients changed their level of physical activ-
ity over time.
Co-morbidities and cancer stage impact on physical ac-
tivity indicated that patients with co-morbidities were
more likely to not be physically active versus those
who did not have co-morbidities (23 % versus 18 %,
p = 0.14 respectively). Similarly, patients with early
stage disease were more likely to be physically active
than those with late stage disease (83 % versus 72 %,
p < .001 respectively).
Lung cancer treatment impact on physical activity is
provided in Table 3. Participants who were physically ac-
tive were more likely to be surgical patients than receiving
chemotherapy or radiation (43, 11 and 11 %, respect-
ively). Similarly, more of the surgical patients (87 %)
were physically active than for the other treatments
(73 %) For survivors who had multiple treatments,
14 % of patients changed in the degree of physical ac-
tivity level after 1 year.
Lung cancer survivor-reported QOL indicated the
benefits of physical activity in all domains (Table 4).
Overall QOL and physical QOL differed by more than
15 points on a 0–100 point scale, roughly equivalent to
one standard deviation, a huge effect size. Emotional
and mental well-being differed by roughly 9 points, lar-
ger than a clinically meaningful effect size of 50 % times
the standard deviation. Lung cancer survivors who were
physically active also reported less pain frequency, pain
severity, dry coughing, coughing with phlegm, SOB, and
fatigue.
Physical activity by time until death analysis indicated
that patients who were within 6 months of death less ac-
tive than patients who were 6 months to a year, versus
more than a year away from death (72, 76, 78 % respect-
ively and p = 0.80).
Disease recurrence rates were the same whether the
patients reported being physically active (81 %) or not
physically active (82 %) (Chi-square test p = 0.62). Over-
all survival however was profoundly different as seen in
Fig. 1 with those who were physically active surviving
an average of 4 more years than those who were not
physically active (8.4 years versus 4.4 years respect-
ively, logrank p < 0.0001). The impact of being physic-
ally active on survival was consistent across disease
stage (early versus late, Fig. 2) and type of lung can-
cer (Non-Small Cell Lung Cancer (NSCLC) vs. Small
Cell Lung Cancer (SCLC), Fig. 3). When covariates
(age at diagnosis, gender, race, disease stage, treat-
ment, smoking status, and pack years) were added to
the survival analysis via a Cox regression model, the
hazard ratio for non-physically active patients to physically
active patients was 1.29 (Table 5, 95 % CI =1.00 to
1.67, p = 0.05).
Cluster analysis of the nine potentially important vari-
ables (Fig. 4) indicated that two clusters formed readily
related to symptoms (pain, fatigue, cough, shortness of
breath, physical active status) and to treatment/disease
status (treatment type, disease stage, smoking status).
Cluster analysis/logistic regression indicated that the
first characteristic differentiating active patients from in-
active patients was fatigue, followed by pain, treatment,
age at diagnosis and smoking status. Collectively these
five items accounted for 19 % of the variance in physical
activity.
Discussion
This large prospective epidemiological study of lung can-
cer survivors provides further support for the premise
that being physical active is beneficial to both quality
and quantity of life. Virtually all QOL domains studied
indicated clinically meaningful advantages for lung can-
cer survivors reporting being physically active versus
those who were not physically active.
These findings are consistent with previous literature
in that the benefits of being active for lung cancer
Table 3 Treatment type by physical activity level
Non-physically active (N = 331) Physically active (N = 1135) Total (N = 1466) p value
Treatment <0.0001*
Missing 12 27 39
Surgery alone 90 (6.3 %) 490 (34.3 %) 580(40.6 %)
Chemo or radio alone 75 (5.3 %) 155 (10.9 %) 230 (16.1 %)
Surgery and chemo or radio 29 (2.0 %) 121 (8.5 %) 150(10.5 %)
Chemo plus radio 67 (4.7 %) 161 (11.3 %) 228 (16.0 %)
Other 58 (4.1 %) 181 (12.7 %) 239 (16.8 %)
*Chi-square test
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Table 4 Quality of life by physical activity level
Non-physically active (N = 331) Physically active (N = 1135) Total (N = 1466) p value*
Emotional well being <0.0001
N 299 1015 1314
Mean (SD) 69.3 (22.1) 77.8 (19.4) 75.9 (20.3)
Deficiency (<=50) 92 (30.8 %) 150 (14.8)
Physical well being <0.0001
N 299 1015 1314
Mean (SD) 54.2 (22.9) 70.8 (20.2) 67.1 (21.9)
Deficiency (<=50) 166 (55.5 %) 229 (22.6 %)
Mental well being <0.0001
N 299 1016 1315
Mean (SD) 71.7 (21.70) 80.1 (18.5) 78.2 (19.6)
Deficiency (<=50) 82 (27.4 %) 120 (11.8 %)
Overall QOL <0.0001
N 299 1014 1313
Mean (SD) 59.3 (23.3) 75.6 (18.8) 71.9 (21.1)
Deficiency (<=50) 140 (46.2 %) 161 (16.0 %)
Frequency of pain <0.0001
N 296 1013 1309
Mean (SD) 57.0 (30.5) 67.4 (29.1) 65.0 (29.7)
Deficiency (<=50) 145 (49.0 %) 339 (33.5 %)
Severity of pain <0.0001
N 296 1014 1310
Mean (SD) 61.4 (27.1) 72.7 (24.7) 70.2 (25.7)
Deficiency (<=50) 129 (43.6 %) 258 (25.4 %)
Frequency of dry coughing 0.0035
N 299 1016 1315
Mean (SD) 67.0 (27.3) 71.7 (27.2) 70.6 (27.3)
Deficiency (<=50) 96 (32.1 %) 273 (26.9 %)
Frequency of coughing with phlegm <0.0001
N 297 1011 1308
Mean (SD) 67.3 (29.4) 75.6 (26.8) 73.7 (27.6)
Deficiency (<=50) 102 (34.3 %) 228 (22.5 %)
Shortness of breath <0.0001
N 299 1018 1317
Mean (SD) 46.9 (27.7) 59.5 (27.4) 56.6 (28.0)
Deficiency (<=50) 191 (63.9 %) 448 (44.0 %)
Level of fatigue <0.0001
N 299 1018 1317
Mean (SD) 39.6 (23.1) 53.9 (24.3) 50.7 (24.8)
Deficiency (<=50) 227 (75.9 %) 555 (54.5 %)
*Wilcoxon
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Fig. 1 Kaplan-Meier survival curves for lung cancer survivors by level of physical activity
Fig. 2 Kaplan-Meier survival curves for lung cancer survivors by stage of disease (early vs late)
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survivors are similar to those for the general population.
The differences were profound in terms of the effect size
benefit for those who are physically active. Recent stud-
ies of the most prevalent and concerning symptoms
among cancer patients indicate that similar to our pa-
tients, fatigue, pain and insomnia are major impacts on
the QOL of lung cancer patient survivors. Smoking con-
tinues to be a profound indicator of well-being for can-
cer patients. The results are also consistent with our
previous work on the prognostic power of overall QOL
on the survival of lung cancer patients30 in that it high-
lights a natural linkage between physical activity, health
promotion behavior, and QOL which together in turn
contribute to the quality and quantity of survival in pa-
tients with lung cancer.
This report provides new information regarding the
specific issues facing lung cancer survivors. Encour-
agingly, the majority of lung cancer survivors do remain
physically active. The deficits observed however are spe-
cific to lung cancer and different from those expressed
by breast cancer survivors for example. Further, this
study identified that physical activity in general was re-
lated to the level of symptoms experienced and the type
of treatments received. In particular, surgical patients
can be expected to be more likely to be physically ac-
tive because they are likely to be earlier stage and less
ill than other patients.
This study has limitations in that it is an observa-
tional rather than a controlled experimental layout.
There could be concomitant influences alongside the
physical activity reporting that could account for the
majority of the apparent impact. For example, per-
formance status and stage of disease could play a role
in determining if a person is physically active or not.
This is unlikely the case in this study however, be-
cause even once these covariates had been included
Fig. 3 Kaplan-Meier survival curves for lung cancer survivors by type of lung cancer (Non-Small Cell Lung Cancer(NSCLC) vs Small Cell
Lung Cancer(SCLC))
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in the survival model, the significance of the physical
activity level remained.
Further, it is acknowledged that obtaining accurate
measures of physical activity is challenging. In this
study we encountered a major barrier in the quality of
the data returned for the Baecke questionnaire. Pre-
sumably in previous validation studies, participants
were given the questionnaire in the presence of study
assistants who could help them answer the relatively
complex and involved questions of the Baecke ques-
tionnaire. Nonetheless, we were able to analyze the in-
dividual items and saw that the results were amazingly
consistent for all 16 questions. Future research is
needed to make this challenging task easier for patients
and scientists to obtain accurate and consistent esti-
mates of physical activity, especially since the impact
of physical activity has demonstrated to have poten-
tially profound impact on patient well-being.
Conclusion
Some recent work described the ability to integrate ob-
jective measures in large cohort design, the future stud-
ies should employ objective measures of physical
activity, such as the accelerometry [40, 41].
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Table 5 Cox regression model
Parameter Hazard ratio 95 % hazard ratio confidence limits P value
Non physically active 1.294 1.003 1.669 0.0472
Age at diagnosis 1.019 1.007 1.031 0.0021
Female 0.828 0.662 1.035 0.0976
Surgery alone 0.414 0.283 0.606 <.0001
Chemo or radio alone 2.333 1.665 3.268 <.0001
Surgery and chemo or radio 0.728 0.468 1.134 0.1602
Chemo plus radio 1.463 1.027 2.085 0.0353
Never smoker 0.890 0.620 1.279 0.5292
Former smoker 1.062 0.824 1.369 0.6418
Overall QOL 0.992 0.987 0.998 0.0057
Fatigue 0.992 0.985 0.998 0.0094
Coughing 1.002 0.997 1.007 0.4913
Shortness of breath 1.003 0.998 1.008 0.2170
Pain 0.997 0.992 1.001 0.1594
Stage I 0.329 0.226 0.479 <.0001
Stage II 0.405 0.250 0.656 0.0002
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